OxThera (Sweden)

A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

Bernd Höppe, Patrick Niaudet, Rémi Salomon et al. · Pediatric Nephrology · 2016 · 83 citations

Antibiotics, Primary Hyperoxaluria, Medicine +3

End Points for Clinical Trials in Primary Hyperoxaluria

Dawn S. Milliner, Tracy L. McGregor, Aliza Thompson et al. · Clinical Journal of the American Society of Nephrology · 2020 · 80 citations · Full text

Effects of <i>Oxalobacter formigenes</i> in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study

Bernd Höppe, Patricia A. Pellikka, Bastian Dehmel et al. · Nephrology Dialysis Transplantation · 2020 · 38 citations

Plasma oxalate: comparison of methodologies

Felicity Stokes, Cécile Acquaviva, Bernd Höppe et al. · Urolithiasis · 2020 · 26 citations · Full text

Urine oxalate biological variation in patients with primary hyperoxaluria

Oliver Clifford-Mobley, Anna Sjögren, Elisabeth Lindner et al. · Urolithiasis · 2016 · 24 citations

Urological Research, Urology, Renal Function +6